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Endotracheal intubation is frequently complicated by laryngeal edema, which may present as postextubation stridor
or respiratory difficulty or both. Ultimately, postextubation laryngeal edema may result in respiratory failure with
subsequent reintubation. Risk factors for postextubation laryngeal edema include female gender, large tube size,
and prolonged intubation. Although patients at low risk for postextubation respiratory insufficiency due to laryngeal
edema can be identified by the cuff leak test or laryngeal ultrasound, no reliable test for the identification of
high-risk patients is currently available. If applied in a timely manner, intravenous or nebulized corticosteroids can
prevent postextubation laryngeal edema; however, the inability to identify high-risk patients prevents the targeted
pretreatment of these patients. Therefore, the decision to start corticosteroids should be made on an individual
basis and on the basis of the outcome of the cuff leak test and additional risk factors. The preferential treatment
of postextubation laryngeal edema consists of intravenous or nebulized corticosteroids combined with nebulized
epinephrine, although no data on the optimal treatment algorithm are available. In the presence of respiratory
failure, reintubation should be performed without delay. Application of noninvasive ventilation or inhalation of a
helium/oxygen mixture is not indicated since it does not improve outcome and increases the delay to intubation.Introduction
Laryngeal edema (LE) is a frequent complication of
intubation and is caused by trauma to the larynx [1, 2].
The edema results in a decreased size of the laryngeal
lumen, which may present as stridor or respiratory dis-
tress (or both) following extubation. Ultimately, postex-
tubation laryngeal edema (PLE) may lead to respiratory
failure with subsequent need for reintubation. Since
reintubation is associated with increased morbidity and
mortality, it is important to prevent reintubation if
possible [3]. Recent studies have focused on several
methods to assess airway patency before extubation,
aiming to identify patients at risk for PLE. This may
enable timely and targeted treatment of patients at risk
for postextubation respiratory failure (PRF). This review
provides an update on this topic, focusing on these re-
cent developments [4].* Correspondence: w.a.pluijms@gmail.com
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PRF may result from liberation failure (i.e., the inability
to ventilate spontaneously without ventilator support) or
extubation failure (i.e., the inability to tolerate removal
of the endotracheal tube) or both [5]. Liberation failure
may result from primary respiratory failure, congestive
heart failure, or neurological impairment. Causes of
extubation failure include upper airway obstruction and
inadequate clearance of airway secretions [5, 6].
Endotracheal intubation causes damage to the airway in
most patients, leading to LE, ulcerations, and damage to
the vocal cords [1, 7–9]. Although these injuries are gener-
ally reversible, they may cause a decrease of the available
airway lumen and lead to respiratory difficulty directly after
extubation [1, 7, 9]. The decreased airway lumen results in
an increase of air flow velocity, leading to postextubation
stridor (PES), which is a clinical marker of relevant PLE. Al-
though the exact quantitative relationship between lumen
narrowing and clinical symptoms is unclear, the presence
of respiratory distress and PES is thought to reflect a nar-
rowing of the airway lumen of more than 50 % [10].le is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
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.org/publicdomain/zero/1.0/) applies to the data made available in this
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Postextubation laryngeal edema and stridor
Earlier studies have reported an incidence of PLE
ranging from 5.0 % to 54.4 % (Table 1) [2, 11–15]. The
large variation may be explained by the lack of a stan-
dardized method to identify LE, resulting in the use of
different definitions of PLE in various studies. Similarly,
the reported incidence of PES varies widely; estimated
incidence ranges from 1.5 % to 26.3 % [1, 14–29].
Postextubation respiratory failure
As mentioned earlier, PRF may result from liberation
failure or extubation failure [5]. The reported overall








Colice et al. [1] 1989 82 5 6.1 % N/A
Ho et al. [17]a 1996 38 10 26.3 % 1
Miller and Cole [22] 1996 100 6 6.0 % 3
Epstein and Ciubotaru [3] 1998 745 N/A N/A 11
Sandhu et al. [21] 2000 110 13 11.8 % 6
De Bast et al. [2] 2002 76 10 13.2 % 8
Jaber et al. [25]b 2003 112 13 11.6 % 9
Maury et al. [20]b 2004 99 4 4.0 % 1
Kriner et al. [18] 2005 462 20 4.3 % 7
Ding et al. [23] 2006 51 4 7.8 % 2
Cheng et al. [16]c 2006 236 18 7.6 % 10
Lee et al. [30]d 2007 325 25 7.7 % 6
Tadié et al. [14] 2010 136 18 13.2 % 4
Cheng et al. [26]c 2011 113 16 14.2 % 11
Gros et al. [27] 2012 104 7 6.7 % 6
Sutherasan et al. [15] 2013 101 16 15.8 % N/A
Mikaeili et al. [28] 2014 41 4 9.8 % N/A
Abbasi et al. [29]a 2014 35 7 20 % N/A
Laryngeal edema
Darmon et al. [12]a 1992 337 17 5.0 % 5
De Bast et al. [2] 2002 76 8 10.5 % 8
Chung et al. [13] 2006 95 35 36.8 % N/A
François et al. [11]a 2007 343 76 22.2 % 11
Tadié et al. [14] 2010 136 74 54.4 % 13
Sutherasan et al. [15] 2013 101 17 16.8 % 2
Adapted from Wittekamp et al. [4]
PES/PLE postextubation stridor/postextubation laryngeal edema, N/A data not availa
aPlacebo group
bOnly reintubation after first extubation attempt was included in analysis
cNonintervention group (cuff leak volume (CLV) ≥24 %) and placebo group combin
dNonintervention group (CLV >110 ml) and placebo group combined1.8 % to 31.4 % (Table 1) [1–3, 11–14, 16–18, 20–23,
25–30]. The reported incidence of reintubation due to
PLE or PES (or both) is 1.1–10.5 %, whereas reintuba-
tion is necessary in 10.0–100 % of patients with PES or
PLE or both. Given the available data, it is unclear what
percentage of PRF is caused by PLE, although from the
available evidence PLE and PES seem to be important
contributors to the overall incidence of PRF.
Risk factors
Several studies have aimed to identify risk factors for PLE
and PES (Table 2) [1, 3, 7, 11, 12, 16–21, 25, 31–33]. Im-
portant risk factors include female gender, longer duration
of intubation, use of large tube size and high cuff pressure,











N/A N/A 9 11 %
2.6 % 10 % N/A N/A
3.0 % 50 % 17 17.0 %
1.5 % N/A 74 9.9 %
5.5 % 46.2 % N/A N/A
10.5 % 80 % 14 18.4 %
8.0 % 69.2 % 11 9.8 %
1.0 % 25.0 % 18 18.2 %
1.5 % 35 % N/A N/A
3.9 % 50 % N/A N/A
4.2 % 55.6 % 14 5.9 %
1.8 % 24.0 % 6 1.8 %
2.9 % 22.2 % 17 12.5 %
9.7 % 68.8 % 14 12.4 %
5.8 % 85.7 % 29 27.9 %
N/A N/A N/A N/A
N/A N/A N/A N/A
N/A N/A 11 31.4 %
1.5 % 29.4 % N/A N/A
10.5 % 100 % 14 18.4 %
N/A N/A N/A N/A
3.2 % 14.5 % 26 7.6 %
9.6 % 17.6 % N/A N/A
2.0 % 11.8 % N/A N/A
ble
ed
Table 2 Risk factors for complications following extubation
Outcome measure Study Year Risk factors
Laryngeal injury Colice et al. [1] 1989 Persistent laryngeal neuromotor activity, tracheostomy
Kastanos et al. [7] 1983 Severe respiratory failure, high cuff pressure,
duration of endotracheal intubation, secretion infection
Esteller-Moré et al. [31] 2005 Longer duration of intubation, tracheostomy, number
of days in the intensive care unit
Laryngeal edema Darmon et al. [12] 1992 Duration of intubation (>36 hours, female gender)
François et al. [11] 2007 Trauma at admission, gender (female), short duration of intubation
(<7 days), smaller height-to-tube diameter ratio, absence of
methylprednisolone pretreatment
Postextubation stridor Cheng et al. [16] 2006 Gender (female), lower Glasgow Coma Scale score, non-sedation
treatment
Sandhu et al. [21] 2000 Duration of intubation (>3 days)
Daley et al. [32] 1996 Tracheostomy, time to reintubation
Ho et al. [17] 1996 Gender (female)
Jaber et al. [25] 2003 High SAPS II, medical patients, difficult intubation, history of
self-extubation, prolonged intubation, high cuff pressure
Kriner et al. [18] 2005 Gender (female), duration on intubation (>6 days), ration tube size
to laryngeal size >45 %
Wang et al. [19] 2007 Gender (female)
Maury et al. [20] 2004 Gender (female)
Erginel et al. [33] 2005 Duration of ventilation (>5 days), body mass index (>26.5)
Reintubation Daley et al. [32] 1996 Tracheostomy, postextubation stidor
Jaber et al. [25] 2003 Postextubation stridor
Epstein and Ciubotaru [3] 1998 APACHE II score, age, cardiopulmonary cause for reintubation
Sandhu et al. [21] 2000 Duration of previous intubation (>3 days)
Adapted from Wittekamp et al. [4]
SAPS II Simplified Acute Physiology Score II, APACHE II Acute Physiology and Chronic Health Evaluation II
Table 3 Measurement of the cuff leak volume in mechanically
ventilated patients
Before performing the cuff leak test, first suction endotracheal and oral
secretions and set the ventilator in the assist control mode.
With the cuff inflated, record displayed inspiratory and expiratory tidal
volumes to see whether these are similar. Record cuff pressure.
Deflate the cuff.
Directly record the expiratory tidal volume over the next six breathing
cycles as the expiratory tidal volume will reach a plateau value after a
few cycles.
Average the three lowest values.
The difference between the inspiratory tidal volume (measured before
the cuff was deflated) and the averaged expiratory tidal volume is the
cuff leak volume.
Reprinted with permission from Wittekamp et al. [4]. Edited from Miller and
Cole [22]
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for PLE and this prevents targeted treatment of high-
risk patients.
Assessment of airway patency before extubation
In an effort to allow identification of patients at risk for
PLE, several tests have been evaluated for the assessment
of airway patency before extubation, including the cuff
leak test (CLT), ultrasonography, and video laryngoscopy.
Cuff leak test
The CLT is an easy-to-perform, non-invasive test which
provides information on the available laryngeal lumen
and has been evaluated in several studies (Tables 3 and 4)
[2, 13, 16, 18–22, 25, 27, 28, 34, 35]. The difference be-
tween the inspiratory tidal volume and the averaged
expiratory tidal volume with the balloon deflated is
defined as the cuff leak volume (CLV). The CLV is then
compared with a predefined cutoff value, yielding a nega-
tive (CLV ≥ cutoff value) or positive (CLV < cutoff value)
result. Whereas the positive predictive value for PES
strongly differs according to the used cutoff value, the
negative predictive value is consistently above 90 % in thestudies addressing this test. In a recent study, the results
of a CLT before extubation were compared with the re-
sults of a CLT performed directly after intubation [27].
Given that no LE is present at intubation, the difference
(ΔCLT) reflects the decrease of available airway lumen
caused by LE [27]. With a cutoff value of 0 ml, indicating
an absence of LE, sensitivity (86 %), specificity (48 %),
Table 4 Predictive value of the cuff leak test and laryngeal ultrasonography for postextubation stridor, laryngeal edema, and
reintubation
Author Year Predefined cutoff value Outcome Sensitivity Specificity PPV NPV
Cuff leak test Volume, ml Percentage of
tidal volume
Miller and Cole [22] 1996 110 Stridor 0.67 (0.51–0.82) 0.99 0.80 0.98
Jaber et al. [25] 2003 130 12 Stridor 0.85 (0.65–0.99) 0.95 (0.91–0.99) 0.69 0.98
De Bast et al. [2] 2002 15.5 Reintubation 0.75 0.72 0.25 0.96
Sandhu et al. [21] 2000 10.0 Stridor or reintubation 0.54 0.96 0.64 0.94
Wang et al. [19] 2007 88 Stridor 0.60 0.89 0.55 0.91
Maury et al. [20] 2004 0 Stridor 1.00 0.80 0.15 1.00
Chung et al. [13] 2006 140 Laryngeal edema 0.89 0.90 0.84 0.93
Engoren [34] 1999 110 Stridor 0.00 0.96 0.00 0.99
Kriner et al. [18] 2005 110 Stridor 0.50 0.84 0.12 0.97
Cheng et al. [16] 2006 18.0 Stridor 0.85 0.72 0.21 0.98
Mikaeili et al. [28] 2014 110 Stridor 0.25 0.84 0.14 0.91
130 0.25 0.81 0.13 0.91
249 0.75 0.59 0.17 0.96
Gros et al. [27] 2012 130 Stridor 0.86 (0.42–1.00) 0.76 (0.67–0.84) 0.21 (0.08–0.40) 0.99 (0.93–1.00)
Sutherasan et al. [15] 2013 110 Laryngeal edema 0.80 0.82 0.46 0.96
Ultrasonography ACWD, mm
Sutherasan et al. [15] 2013 1.6 Laryngeal edema 0.71 0.70 0.32 0.92
Mikaeili et al. [28] 2014 0.85 Stridor 0.50 0.57 0.11 0.91
95 % confidence intervals are provided if available
Adapted from Wittekamp et al. [4]
PPV positive predictive value, NPV negative predictive value, ACWD air column width difference
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value (99 %) were calculated and they were not su-
perior to those of conventional CLT. Therefore, the CLT
is mainly effective in identifying patients not at risk for
PLE or PES.
The poor performance of the CLT in the identification
of high-risk patients might be explained in part by the
relatively low prevalence of PLE and PES in most studies
on the predictive value of the CLT. However, the low
positive predictive value of the CLT for PLE and PES
might be explained by the characteristics of the test as
well and this has been shown in a physiological study
[36]. For an optimal positive predictive value of the CLT,
the cross-sectional area around the deflated cuff should
be the only determinant of the CLV. However, this study
indicated that the outcome of the CLT is significantly
affected by the inspiratory leak volume since the expira-
tory leak volume is only 30 % of the total leak volume.
This inspiratory leak volume is significantly affected by
the respiratory system compliance and inspiratory flow,
which are therefore additional determinants of the CLV.
Therefore, the timing of cuff deflation is important, and
ideally the cuff should be deflated immediately prior to
expiration to eliminate the inspiratory leak volume.However, to the best of our knowledge, no published
studies have compared the conventional CLT with an
adapted version of the CLT, in which the cuff is deflated
only during expiration.
Ultrasonography
Several studies on the assessment of airway patency
using ultrasonography have been published in recent
years [15, 23, 28]. Using ultrasonography, the air column
width (ACW), which is defined as the width of the
acoustic shadow present at the level of the vocal cords,
can be measured. If the ACW is measured before and
after endotracheal cuff deflation, the air column width
difference (ACWD) can be calculated. Results from the
study by Ding et al. showed a significantly lower ACWD
(0.35 versus 1.5 mm; P < 0.01) and lower ACW during
cuff deflation (4.5 versus 6.4 mm; P = 0.01) in patients
who developed a stridor compared with patients who
did not [23]. Owing to the small sample size (n = 51),
including only four patients with PES, results from
this study should be interpreted with caution. In the
study by Sutherasan et al., similar results were found
with decreased ACW after cuff deflation (5.97 versus
6.87 mm; P < 0.05) and ACWD (1.08 versus 1.99 mm;
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tunately, these results could not be replicated in the
study by Mikaeili et al. [28]. They reported no signifi-
cant difference regarding ACW before deflation (12 versus
11.5 mm; P = 0.48) or ACWD (0.1 versus 1.0 mm; P =
0.59) between patients with and without PES. This might
be explained by the small sample size (n = 41) and
the subsequent small number of patients developing
PES (n = 4). Further statistical analysis of available evi-
dence indicates that ultrasonography has a low posi-
tive predictive value, sensitivity, and specificity for
predicting PES or PLE or both (Table 4). However,
these findings should be interpreted with caution since
available evidence is limited to small-scale studies with
only small numbers of patients with PES or PLE or both.
Video laryngoscopy
Results on the use of video laryngoscopy for the assess-
ment of airway patency have been published in one case
series, including only three patients [37]. The case series
included two patients with PES and one patient with LE
secondary to extensive airway manipulation due to an
unanticipated difficult airway of unknown cause. In these
patients, it was shown that video laryngoscopy enables
visualization of periglottic structures and pathology.
Whereas the CLT cannot differentiate PLE from structural
laryngeal lesions or laryngeal spasm, video laryngoscopy
or flexible endoscopy might potentially enable identifica-
tion of the cause of the laryngeal narrowing and thus
guide treatment. However, further studies on the added
value of video laryngoscopy or flexible endoscopy (or
both) in the prediction of PLE and PES as well as the diag-
nostic approach of laryngeal narrowing are needed before
they can be implemented in clinical practice.
Prevention
Elimination of possible risk factors might prevent PLE
and thus decrease the incidence of PLE. Firstly, an
adequate-size endotracheal tube should be selected.
Generally accepted maximum endotracheal tube sizes
are 7.0 mm for women and 8.0 mm for men. However,
smaller endotracheal tubes may interfere with endo-
scopic endotracheal procedures and increase the work of
breathing and this should be taken into account during
the weaning process. Secondly, the duration of intubation
should be minimized since the duration of intubation in
patients with PES is consistently increased compared with
patients without PES. No data on a potential cutoff length
of intubation increasing the risk for PES are available;
however, in general, extubation should not be postponed
in order to prevent unnecessary prolongation of intub-
ation. The application of noninvasive ventilation (NIV)
might facilitate early detubation, although no data on the
effect of early detubation combined with NIV on PES havebeen published. Thirdly, cuff pressures should be mea-
sured regularly to prevent formation of pressure ulcers
due to high cuff pressure. Although no evidence on the
maximum acceptable cuff pressure is available, 25 cm
H2O is a widely accepted upper limit [38]. Since the use of
continuous cuff pressure monitoring is also associated
with a decreased incidence of ventilator-associated pneu-
monia, the use of continuous cuff pressure monitoring
should be strongly advised [39].
Several studies have investigated the use of intraven-
ously administered corticosteroids in the prevention of
LE (Table 5), and initial studies failed to show a benefi-
cial effect of corticosteroids on PLE [12, 17]. However,
in more recent studies, corticosteroids were shown to
decrease the incidence of PLE by more than 50 %
(Table 5) [11, 16, 26, 30]. This difference is probably
caused by the implementation of different treatment al-
gorithms. Whereas in the initial studies extubation was
performed 1 hour after the administration of the cortico-
steroids, later studies implemented different treatment
algorithms with at least 4–48 hours between administra-
tion of corticosteroids and extubation. Furthermore, in
later studies, low-risk patients were identified by the
CLT and excluded from the study, resulting in a study
group with a higher risk for PLE. In a recent trial, corti-
costeroids (budesonide) were nebulized following extu-
bation and compared with nebulized saline, showing
more than 50 % reduction in the incidence of respiratory
distress and need for reintubation [29]. However, it
should be noted that, although a CLT was performed,
low-risk patients were not excluded on the basis of the
outcome of the CLT.
From these studies, it can be concluded that intraven-
ously administered corticosteroids are effective in the pre-
vention of PLE if started several hours before extubation.
This conclusion was supported by two meta-analyses, stat-
ing that data from the latest well-designed studies suggest
that the incidence of PLE and associated PRF is reduced if
intravenously administered corticosteroids are started
12–24 hours before extubation and if multiple doses
are administered [40, 41]. However, it should be noted
that in the most recent trial corticosteroids were started
only 4 hours before extubation and a similar reduction of
PLE and reintubation rate was observed [26]. Further-
more, recent data suggest that administration of neb-
ulized corticosteroids following extubation might well
be as effective as intravenously administered cortico-
steroids [29]. Therefore, further research is needed to
identify the optimal route of administration and treat-
ment algorithm. Perhaps more importantly, future re-
search should focus on the identification of patients
at risk for PLE and associated PRF, enabling targeted treat-
ment of these patients and prevention of unnecessary
treatment of low-risk patients.
Table 5 The effect of corticosteroids on postextubation laryngeal edema, stridor, respiratory distress, and reintubation
Author Year Intervention Time before extubation Intervention group Control group
Outcome parameter Number Percentage Outcome parameter Number Percentage P value
Darmon et al. [12] 1992 Dexamethasone 8 mg i.v. 1 hour Laryngeal edema 11/327 3.4 % Laryngeal edema 17/337 5.0 % ns
Ho et al. [17] 1996 Hydrocortisone 100 mg i.v. 1 hour Laryngeal edema 7/39 17.9 % Laryngeal edema 10/38 26.3 % ns
Cheng et al. [16] 2006 Methylprednisolone 40 mg i.v. 24 hours Stridor 5/43 11.6 % Stridor 13/43 30.2 % 0.15
Reintubation 3/43 6.9 % Reintubation 11/43 25.6 % NA
Methylprednisolone 4 × 40 mg i.v. 24 hours Stridor 3/42 7.1 % Stridor 13/43 30.2 % 0.005
Reintubation 7/42 16.7 % Reintubation 11/43 25.6 % NA
François et al. [11] 2007 Methylprednisolone 3 × 20 mg i.v. 12 hours Laryngeal edema 11/355 3.1 % Laryngeal edema 76/343 22. % <0.01
Reintubation 13/355 3.7 % Reintubation 36/343 10.5 % 0.02
Lee et al. [30]a 2007 Dexamethasone 4 × 5 mg i.v. 48 hours Stridor 4/40 10 % Stridor 11/40 27.5 % 0.037
Reintubation 1/40 2.5 % Reintubation 2/40 5.0 % 0.56
Cheng et al. [26]b 2011 Methylprednisolone 40 mg i.v. 4 hours Stridor 6/38 15.8 % Stridor 13/33 39.4 % 0.025
Reintubation 3/38 7.9 % Reintubation 10/33 30.3 % NA
Abbasi et al. [29] 2014 Budesonide 4 × 1 mg nebulized 48 hours Respiratory distress 3/35 8.6 % Respiratory distress 11/35 31.4 % 0.017
Stridor 3/35 8.6 % Stridor 7/35 20 % 0.17
Reintubation 3/35 8.6 % Reintubation 11/35 31.4 % 0.017
i.v. intravenous, ns not significant, NA not applicable
aOnly patients with cuff leak volume (CLV) <110 ml were included. In patients with CLV ≥110 ml, stridor was found in 4.9 % of patients, and 1.4 % of patients were reintubated
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Reintubation should be performed without delay in the
presence of respiratory insufficiency due to PLE. Al-
though NIV has been shown to be effective in the pre-
vention of intubation in respiratory insufficiency in
general, it was shown to be ineffective in the treatment
of respiratory insufficiency following extubation [42].
More than that, NIV for PRF has been associated with
increased mortality, probably due to the increased delay
to intubation [43]. Therefore, the use of NIV for PRF
failure cannot be recommended.
The use of airway exchange catheters (AECs), which
has been included in the Difficult Airway Society extu-
bation guidelines for patients at risk for PRF, providesFig. 1 Proposed extubation algorithm. AEC airway exchange catheter, CLVimportant advantages [44]. Firstly, the AEC may facili-
tate over-the-wire insertion of an endotracheal tube in
the instance of difficult visualization of the glottis and this
is not uncommon in the presence of LE [45]. Secondly,
the development of the Ventrain® (Ventinova Medical
B.V., Eindhoven) device has made emergency ventilation
through a narrow-bore catheter possible [46]. Unfortu-
nately, identification of patients at risk for PRF is difficult
since no reliable test is available.
The current treatment of choice for PLE consists of
intravenous corticosteroids and nebulized epinephrine.
Corticosteroids decrease LE by diminishing the inflamma-
tory response and decreasing capillary vessel dilation and
permeability. However, the efficacy of corticosteroids incuff leak volume. Adapted from Wittekamp et al. [4]
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no data on the most effective dose are available. Based on
the dosages used in the prevention of PLE, a dosage of
methylprednisolone 20–40 mg or dexamethasone 5 mg
could be suggested and therapy might be continued for
24–48 hours after extubation [11, 16, 26, 30].
Nebulized epinephrine is thought to decrease LE
through vasoconstriction, although high-quality evidence
on the efficacy is lacking. In pediatric upper airway ob-
struction caused by severe viral croup, it has been shown
to decrease upper airway obstruction scores, and a bene-
ficial effect has been suggested in upper airway obstruc-
tion of other etiologies [47–49]. The optimal dosage is
currently unknown, although 1 mg in 5 ml has been sug-
gested [49].
The efficacy of combined intravenous corticosteroids
and nebulized epinephrine on PLE has been investigated
in pediatric patients, although administration of cortico-
steroids was started before extubation and treatment
was not limited to symptomatic patients [50]. In this
overall well-designed study, dexamethasone and nebu-
lized epinephrine did not prevent clinical progression of
airway obstruction due to PLE. Therefore, the efficacy of
both intravenous corticosteroids and nebulized epineph-
rine as well as the combination of both treatments has
not been established.
The inhalation of a helium-oxygen mixture (heliox)
decreases airway resistance and thus work of breathing.
Although no evidence on the efficacy of heliox administra-
tion in adult PLE is available, a 38 % reduction in respira-
tory distress score was reported in children with PES,
although no change in outcome was found [51]. There-
fore, heliox does not lead to a reduction of LE but may
decrease work of breathing and buy time to establish a
definitive solution for the upper airway obstruction and
this may be useful in circumstances in which it is difficult
to intubate patients. However, in the context of PLE, it
should (similar to NIV) not lead to a delay to intubation
since that may potentially lead to a worse outcome.
Based on the best available evidence, a practical extu-
bation algorithm, including prevention and treatment of
PLE and PRF, may be proposed (Fig. 1). However, it
should be emphasized that the CLT effectively identifies
low-risk patients only. Treatment of all patients with a
positive CLT would result in overtreatment. Therefore,
one could decide to perform a CLT in all patients and
start pretreatment with corticosteroids in the presence
of additional risk factors only, as suggested in the algo-
rithm. Alternatively, a CLT could be performed in pa-
tients with risk factors only.
Conclusions
PLE is a frequent complication of intubation and leads
to reintubation in up to 10 % of all extubated patients.Pretreatment with intravenous corticosteroids or admin-
istration of nebulized corticosteroids following extuba-
tion seems fairly effective in the prevention of PLE,
decreasing the need for reintubation by more than 50 %.
However, the lack of reliable predictors prevents identifi-
cation of patients at high risk for PLE and PRF. Patients
with a low risk of PLE and PRF can be identified by
using the CLT, which is therefore advisable. In patients
with a positive CLT, the decision to start pretreatment
with corticosteroids should be made on an individual
basis and on the basis of the presence of additional risk
factors. If corticosteroid therapy is considered to be indi-
cated, treatment should be started at least 4 hours before
extubation and multiple doses should be administered. If
PES or PLE is present, the treatment of choice should be
corticosteroids combined with nebulized epinephrine.
However, if PLE or PES leads to respiratory insufficiency,
reintubation is the only definitive resolution and should
not be postponed.
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